How is SPY stock faring? The SPDR S&P 500 ETF Trust is up 1.44% in the past 5 days and about 10.91% over the past year.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
According to TipRanks’ unique ETF analyst consensus, determined based on a weighted average of its holdings’ analyst ratings, SPY is a Moderate Buy. The Street’s average price target of $651.39 implies an upside of more than 10.86%.
Currently, SPY’s five holdings with the highest upside potential are UnitedHealth (UNH), Biogen (BIIB), Alexandria Equities (ARE), Moderna (MRNA), and Bio-Techne (TECH).
Meanwhile, its five holdings with the greatest downside potential are Palantir Technologies (PLTR), Tesla (TSLA), Super Micro Computer (SMCI), Franklin Resources (BEN), and NRG Energy (NRG).
Revealingly, SPY’s ETF Smart Score is seven, implying that this ETF is likely to perform in line with the market.
Power up your ETF investing with TipRanks. Discover the Top Equity ETFs with High Upside Potential, carefully curated based on TipRanks’ analysis.